Fluorometholonedrug info
fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]
What it is used for
FML FORTE ® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective February 13, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
FML FORTE ® (fluorometholone ophthalmic suspension, USP) 0.25% is a sterile, topical anti-inflammatory agent for ophthalmic use.
Chemical N ame Fluorometholone: 9-Fluoro-11ß, 17-dihydroxy-6α-methylpregna-1,4-diene-3,20-dione Structural Formula Contains Active: fluorometholone 0.25%.
Preservative: benzalkonium chloride 0.005%.
Inactives: edetate disodium; polysorbate 80; polyvinyl alcohol 1.4%; purified water; sodium chloride; sodium phosphate, dibasic; sodium phosphate, monobasic; and sodium hydroxide to adjust pH. FML FORTE ® suspension is formulated with a pH from 6.2 to 7.5. The Structural Formula for Fluorometholone is 9-Fluoro-11ß, 17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective February 13, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance